Co-Op, Quality Assurance & Compliance
Moderna
Summary
This is a winter / spring co-op opportunity in Norwood, MA from January 18, 2027 – June 25, 2027. Applicants must be available for the entire duration of the co-op. The Quality Assurance Co-op will be part of a cohesive team supporting cGMP materials produced internally at Moderna. This role will provide hands-on exposure to quality oversight activities and Moderna’s Quality System while partnering with experienced team members to support compliant manufacturing operations and global regulatory expectations. This position is site-based, requiring you to be at Moderna’s site full-time. This position is not eligible for remote work.
Job description
Here’s What You’ll Do
- Support compliance activities and learn the fundamentals of quality systems.
- Collaborate with Quality and cross-functional teams on daily activities and improvement projects.
- Help draft and review SOPs, policies, batch records, testing records, and training materials.
- Review electronic and paper batch records for completeness and cGMP compliance.
- Observe manufacturing activities and support compliance with procedures, specifications, and cleanroom practices.
- Follow written procedures and maintain clear, accurate, and complete documentation.
- Complete required training and follow data integrity principles.
- Identify and promptly escalate manufacturing, safety, and quality concerns.
- Support deviation documentation, investigations, and corrective actions.
- Support regulatory and inspection readiness activities, including internal audits and health authority engagement.
- Collect, analyze, and report quality metrics to identify trends and improvement opportunities.
- Use problem-solving skills to support quality and operational improvements.
- Lead assigned quality projects from planning through completion with guidance.
- Manage priorities and contribute to multiple projects at the same time.
- Follow Moderna’s safety procedures and practice safe work habits.
- Additional duties as assigned.
Here’s What You’ll Bring to the Table (Basic Qualifications)
- Current student enrolled in a Bachelors or Masters program in Science related fields or Regulatory Affairs.
- Interest in learning about cGMP manufacturing, quality systems, batch record review, deviation management, and inspection management.
- Strong written and verbal communication skills, attention to detail, a collaborative mindset, and a willingness to ask questions and escalate quality or safety concerns appropriately.
Here’s What You’ll Bring to the Table (Preferred Qualifications)
- GPA of 3.5 on a 4 scale or equivalent.
- Demonstrated ability to work both independently as well as the ability to contribute to high performing teams.
- Excellent written and verbal communication skills.
- A desire to make an impact as part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative.
Requirements
- Current student enrolled in a Bachelors or Masters program in Science related fields or Regulatory Affairs
- Interest in learning about cGMP manufacturing, quality systems, batch record review, deviation management, and inspection management
- Strong written and verbal communication skills
- Attention to detail
- Collaborative mindset
- Willingness to ask questions and escalate quality or safety concerns appropriately
- GPA of 3.5 on a 4 scale or equivalent
- Demonstrated ability to work both independently and contribute to high performing teams
- Excellent written and verbal communication skills
Benefits
- Meditation and mindfulness classes
- Subsidized commuter benefits
- Paid time off
- Vacation
- Sick time
- Holidays
- Volunteer days
- Discretionary year-end shutdown
- Location-specific perks
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.